Trial Profile
RANDOMIZED TRIAL OF LIMUS-ELUTING STENTS WITH BIODEGRADABLE OR PERMANENT POLYMER COATINGS REGARDING STENT COVERAGE ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms TEST-6-OCT
- 04 Jan 2012 Actual patient number is 48 according to ClinicalTrials.gov.
- 04 Jan 2012 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 04 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.